Executive Committee & Leadership
Alexis Bio's Executive Committee
Steve Gullans, Ph.D., M.B.A.
Chairman, Board of Directors
Steve is an experienced biotech executive, venture investor, scientist, entrepreneur, and author. He currently advises life science companies on strategy.
Travis H. Brown, M.B.A.
Executive Vice Chairman and Chief Strategy Officer
Travis H. Brown has served as Alexis Bio's Executive Vice Chairman of the Board of Directors since April 2021. In this role, he directs the company’s regulatory affairs, intellectual property, and commercial license development responsibilities.
Paul Holzer, D.Eng(c), M.Eng., M.S., M.B.A.
Chief Executive Officer and Co-Founder
Paul Holzer has served as Alexis Bio’s (formerly XenoTherapeutics Corporation) since January 2016. Before founding the company,
Carlos Rivera, M.B.A.
Chief Financial Strategist
Carlos Rivera has served as an Alexis Bio board member since March 2021. Before joining the company, Mr. Rivera served as Partner at Summit Action LLC, a venture capital firm focused on growth investing from 2016-2021.
Krysta Moulton, M.S., CPA
Board of Directors & Co-Founder
Krysta Moulton is a Co-Founder of Alexis Bio and serves as a senior member of the Board of Directors, as well as Co-Founder of XenoTherapeutics Foundation.
Scientific Advisory Board
Originally founded in 2016 as XenoTherapeutics,
Alexis Bio is now a clinical-stage company with
a robust pipeline of promise.
Our dedicated team of engineers, biologists, and leaders are always looking to hire those with a passion for new proteins, cells, tissues, and organs.